Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.
about
Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic MiceAdult hippocampal neurogenesis in Parkinson's disease: impact on neuronal survival and plasticityNeuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunityIntrastriatal transplantation of adult human neural crest-derived stem cells improves functional outcome in parkinsonian ratsIncreased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits.Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease.Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson's DiseaseElevated homocysteine by levodopa is detrimental to neurogenesis in parkinsonian modelEnvironmental Exposures and Parkinson's DiseaseGDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson diseaseElectrochemical Analysis of NeurotransmittersAntioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatumDopamine receptor activation promotes adult neurogenesis in an acute Parkinson modelDopaminergic Contributions to Vocal LearningChemical Control of Grafted Human PSC-Derived Neurons in a Mouse Model of Parkinson's DiseaseDopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.Traditional Chinese medicine for modern treatment of Parkinson's disease.Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease.Protective effect of tetrahydroxystilbene glucoside on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway.Protective effects of octacosanol on 6-hydroxydopamine-induced Parkinsonism in rats via regulation of ProNGF and NGF signaling.Potential future neuroprotective therapies for neurodegenerative disorders and stroke.Effects of Pharmacological Block of GABA(A) Receptors on Pallidal Neurons in Normal and Parkinsonian State.Bioactive marine drugs and marine biomaterials for brain diseasesInfluence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's DiseaseTRPC1 inhibits apoptotic cell degeneration induced by dopaminergic neurotoxin MPTP/MPP(+).Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease.An in vivo microdialysis study of FLZ penetration through the blood-brain barrier in normal and 6-hydroxydopamine induced Parkinson's disease model rats.Modeling nigrostriatal degeneration in organotypic cultures, a new ex vivo model of Parkinson's diseaseNatural toxins implicated in the development of Parkinson's disease.Metal imaging in neurodegenerative diseases.Systemic administration of 6-OHDA to rhesus monkeys upregulates HLA-DR expression in brain microvasculatureProtective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease.PET imaging a MPTP-induced mouse model of Parkinson's disease using the fluoropropyl-dihydrotetrabenazine analog [18F]-DTBZ (AV-133)Sanguisorbae radix protects against 6-hydroxydopamine-induced neurotoxicity by regulating NADPH oxidase and NF-E2-related factor-2/heme oxygenase-1 expressions.Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cellsA rat model of striatonigral degeneration generated by simultaneous injection of 6-hydroxydopamine into the medial forebrain bundle and quinolinic acid into the striatum.The endotoxin-induced neuroinflammation model of Parkinson's disease.Photobiomodulation preserves behaviour and midbrain dopaminergic cells from MPTP toxicity: evidence from two mouse strains.Cucurbitacin E has neuroprotective properties and autophagic modulating activities on dopaminergic neuronsPhloroglucinol attenuates motor functional deficits in an animal model of Parkinson's disease by enhancing Nrf2 activity.
P2860
Q26773064-3312F34F-ADAB-4508-8E4C-D17D4CF688D3Q26862840-46D9A4B9-731A-4623-AB11-B022D20AB0F6Q27027973-41913EFA-189A-42DF-AB5F-622774E6F57DQ27301260-718CDD78-34A0-4E46-A4AD-1AEE5ED18FBBQ27308109-B505869E-EBA8-4C61-A609-8E06AB313B13Q27311318-9E96554E-29B8-4637-9F6C-A12447149D61Q27320553-469663D9-03DE-4054-A59E-2043D29A777DQ27334004-E2105218-73D8-46F3-A098-76D14AE5E647Q28074723-9BAD6DE8-AB0B-4C8E-991D-348D1FF0E806Q28083626-BB61C751-2C1E-45E2-BE80-F5B66C454ED5Q28084958-7CF4C0E9-03CB-495F-92B1-9F0CF394A2E7Q28566901-D7C14173-CCE1-48B5-BAC8-52F678F9592AQ28579481-B99B860D-ACFD-4C34-AEDB-DF63733C0727Q28604197-BA15DF50-4F7D-407D-8F8E-33614AB20513Q28829174-1B146DF7-563D-48E0-B8D1-CF934AA91F19Q30372768-5B617CF0-1354-4BA9-ACA5-26E75B3A816BQ30572208-49378A37-48F9-427F-87AF-2529F7AA6B38Q30895929-73E4D129-0D6D-4E62-8D85-A7AF641D8126Q31038097-62652B75-DEE7-4620-8C2D-8095FA71E49AQ33557497-37E32ACC-C30B-48FC-9B8A-5878B2924FC3Q33687436-004FEE42-D2FA-4DFD-B4E9-45CF4CCF6209Q33701415-769CD840-F569-49B6-8655-56D71CFF7E8AQ33736687-B93420D0-39E1-4D75-8187-39A6247989A2Q33740654-93305636-CD37-4C6C-A770-BBC928868CBEQ33797760-918F671B-FA3D-417C-9FF9-1636D27DB6B2Q33835301-A2BE51B4-3A4B-4C6B-BFF9-B2777200A77DQ33876743-D993F67D-39AA-4AA2-856E-E79E787031F9Q33924432-FA835DED-2073-4F52-9867-D8138223001BQ34029794-88930FE3-226F-4ACF-95F3-57FA74844E13Q34073566-D82AD3A6-0491-4738-B946-95E29804CC4BQ34237258-FA9861A9-BB96-4B30-B446-3629C3559500Q34269340-01125B38-AA1A-479D-982E-8D8E6EB97CEEQ34314094-9B209910-4133-4A50-884D-40843F244435Q34397803-979AF82D-8EE3-4322-9826-C295C8EBF62AQ34505750-F0B12835-E898-4D5A-96D8-6AFD09B28CD4Q34528632-175AC4B3-F8D6-43B1-A1D7-13897DC74B35Q34557246-CF6E14A2-7E17-48BB-B12B-8FD2BE5F4CEAQ34636743-2AB23206-AEA9-4807-80C8-2C8FEDC8A2E5Q34770689-97B6E698-897B-4D2F-B910-7B36077DC6F7Q34970674-36B5206F-E871-4F81-918E-AF52FE629B07
P2860
Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.
@ast
Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.
@en
Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.
@nl
type
label
Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.
@ast
Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.
@en
Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.
@nl
prefLabel
Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.
@ast
Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.
@en
Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.
@nl
P1476
Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.
@en
P2093
Andreas Schober
P2888
P304
P356
10.1007/S00441-004-0938-Y
P577
2004-07-28T00:00:00Z
P6179
1000240995